Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-05 Sale | 2024-02-06 6:26 pm | OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO | 19,642 | $4.86 | $95,460 | 1,144,601 (Indirect Direct) | View |
| 2024-01-31 Sale | 2024-02-02 7:00 pm | OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO | 18,338 | $4.95 | $90,773 | 434,443 (Indirect Direct) | View |
| 2023-08-30 Purchase | 2023-09-05 08:27 am | OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO | 6,500 | $3.81 | $24,765 | 452,781 (Indirect Direct) | View |
| 2023-02-06 Sale | 2023-02-08 7:29 pm | OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO | 19,669 | $4.24 | $83,397 | 446,281 (Direct) | View |
| 2021-08-20 Purchase | 2021-08-24 08:49 am | OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO | 5,000 | $9.89 | $49,450 | 102,900 (Direct) | View |
| 2019-06-06 Purchase | 2019-06-10 4:53 pm | OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President & CEO | 40,000 | $2.81 | $112,400 | 97,900 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-03 Option Award | 2024-02-06 6:26 pm | N/A 2034-02-02 | OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO | 729,800 | $0 | 1,144,601 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 4:57 pm | N/A 2033-06-07 | Aura Biosciences Inc. | AURA | Mattessich Antony C. Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 7:32 pm | N/A 2033-01-29 | OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO | 713,200 | $0 | 1,002,850 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 5:06 pm | N/A 2032-06-15 | Aura Biosciences Inc. | AURA | Mattessich Antony C. Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2022-02-03 Option Award | 2022-02-07 7:28 pm | N/A 2032-02-02 | OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO | 746,950 | $0 | 849,850 (Direct) | View |
| 2021-10-28 Option Award | 2021-10-29 7:27 pm | N/A 2031-10-27 | Aura Biosciences Inc. | AURA | Mattessich Antony C. Director | 16,000 | $0 | 16,000 (Direct) | View |
Ownership | 2021-10-28 8:22 pm | N/A 2031-09-22 | Aura Biosciences Inc. | AURA | Mattessich Antony C. Director | 0 | $0 | 53,649 (Direct) | View |
| 2021-02-17 Option Award | 2021-02-19 4:30 pm | N/A 2031-02-16 | OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO | 455,000 | $0 | 455,000 (Direct) | View |
| 2020-01-30 Option Award | 2020-02-03 6:28 pm | N/A 2030-01-29 | OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO | 360,000 | $0 | 360,000 (Direct) | View |